CNBC   |  April 01, 2013

Johnson & Johnson Hits All-Time High

Johnson & Johnson just won approval for a new diabetes drug, and the stock is at an all-time high today. Anthony Butler, Barclays, offers insight.

Share This:

Sorry, we do not have a transcript available for this video at this time.